Steve Projan

1.1k total citations
6 papers, 200 citations indexed

About

Steve Projan is a scholar working on Molecular Biology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Steve Projan has authored 6 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Infectious Diseases and 2 papers in Molecular Medicine. Recurrent topics in Steve Projan's work include Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial biofilms and quorum sensing (3 papers) and Antibiotic Resistance in Bacteria (2 papers). Steve Projan is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial biofilms and quorum sensing (3 papers) and Antibiotic Resistance in Bacteria (2 papers). Steve Projan collaborates with scholars based in United States and Canada. Steve Projan's co-authors include Mirjana Nesin, Paul M. Dunman, Hattie D. Gresham, Ambrose L. Cheung, Patricia A. Bradford, Hermı́nia de Lencastre, Agnes Marie Sá Figueiredo, Juliette O’Connell, Alexander Tomasz and Gary J. Noel and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, BMC Genomics and The Pediatric Infectious Disease Journal.

In The Last Decade

Steve Projan

6 papers receiving 187 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steve Projan United States	5	119	102	55	35	35	6	200
G. C. Kedar Spain	7	164 1.4×	153 1.5×	77 1.4×	33 0.9×	12 0.3×	8	281
Jeffrey Alder United States	9	137 1.2×	121 1.2×	47 0.9×	65 1.9×	27 0.8×	17	301
Arabela Cuirolo Argentina	8	231 1.9×	158 1.5×	72 1.3×	20 0.6×	38 1.1×	10	283
Caroline Manzano Switzerland	5	87 0.7×	94 0.9×	27 0.5×	11 0.3×	15 0.4×	8	166
Kathryn McLean United States	7	49 0.4×	110 1.1×	86 1.6×	19 0.5×	10 0.3×	10	216
Naoko Imuta Japan	9	101 0.8×	76 0.7×	55 1.0×	12 0.3×	10 0.3×	20	291
Qun Wang China	5	211 1.8×	159 1.6×	27 0.5×	12 0.3×	54 1.5×	8	311
Audun Sivertsen Norway	9	125 1.1×	98 1.0×	98 1.8×	15 0.4×	43 1.2×	17	270
Jaime L. Little United States	10	161 1.4×	157 1.5×	39 0.7×	11 0.3×	31 0.9×	14	280
HaroldW. Jaffe United States	4	165 1.4×	105 1.0×	45 0.8×	16 0.5×	17 0.5×	4	265

Countries citing papers authored by Steve Projan

Since Specialization

Citations

This map shows the geographic impact of Steve Projan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Projan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Projan more than expected).

Fields of papers citing papers by Steve Projan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Projan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Projan. The network helps show where Steve Projan may publish in the future.

Co-authorship network of co-authors of Steve Projan

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Projan. A scholar is included among the top collaborators of Steve Projan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Projan. Steve Projan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Projan, Steve, Mirjana Nesin, & Paul M. Dunman. (2006). Staphylococcal vaccines and immunotherapy: to dream the impossible dream?. Current Opinion in Pharmacology. 6(5). 473–479. 74 indexed citations

2.

Weiss, Jason, Peter J. Petersen, Timothy M. Murphy, et al.. (2004). In Vitro and In Vivo Activities of Novel 6-Methylidene Penems as β-Lactamase Inhibitors. Antimicrobial Agents and Chemotherapy. 48(12). 4589–4596. 41 indexed citations

3.

Haney, Steven A., David Keeney, Lei Chen, et al.. (2003). Increased retention of functional fusions to toxic genes in new two-hybrid libraries of the E. coli strain MG1655 and B. subtilis strain 168 genomes, prepared without passaging through E. coli. BMC Genomics. 4(1). 36–36. 4 indexed citations

4.

DeCenzo, Maureen T., Mike Kuranda, John Babiak, et al.. (2002). Identification of Compounds That Inhibit Late Steps of Peptidoglycan Synthesis in Bacteria.. The Journal of Antibiotics. 55(3). 288–295. 21 indexed citations

5.

Cheung, Ambrose L., Steve Projan, & Hattie D. Gresham. (2002). The genomic aspect of virulence, sepsis, and resistance to killing mechanisms in Staphylococcus aureus. Current Infectious Disease Reports. 4(5). 400–410. 29 indexed citations

6.

Noel, Gary J., Barry N. Kreiswirth, Paul J. Edelson, et al.. (1992). Multiple methicillin-resistant Staphylococcus aureus strains as a cause for a single outbreak of severe disease in hospitalized neonates. The Pediatric Infectious Disease Journal. 11(3). 184–188. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact